Top Markets
#1 Pleasing Gold Pleasing Gold +1,546.27%
#2 PulseChain PulseChain +55.72%
#3 Ontology Gas Ontology Gas +36.94%
#4 DogBull DogBull +36.89%
#5 BOOK OF MEME BOOK OF MEME +30.55%
#6 Neiro Neiro +21.85%
#7 Collect on Fanable Collect on Fanable +21.43%
#8 Nockchain Nockchain +19.56%
#9 Pump.fun Pump.fun +19.14%
#10 Unit Pump Unit Pump +19.14%
Coin of the day
Pleasing Gold Pleasing Gold
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Clasificación en acciones #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Precio por acción
$0.12164306
Última sincronización: 2024-11-11
Capitalización bursátil
$38.53M
Cambio (1 día)
-4.14%
Cambio (1 año)
0.00%
País
AU
Comercio PharmAust Limited (PAA)

Categoría

Healthcare
Ganancias de PharmAust Limited (PAA)
Ganancias en Jun 2024 TTM: $-6.31M
Secondo gli ultimi rapporti finanziari di PharmAust Limited, gli utili attuali della società sono $-6.31M. Nel 2023, la società ha registrato un utile di $-4.14M, una disminución en comparación con agli utili del 2022, che erano di $-1.18M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de PharmAust Limited desde 2001 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-6.31M 0.00%
2024 $-6.31M 52.51%
2023 $-4.14M 251.26%
2022 $-1.18M 17.50%
2021 $-1.00M 6.70%
2020 $-939.77K -13.74%
2019 $-1.09M -41.67%
2018 $-1.87M 80.51%
2017 $-1.03M -64.63%
2016 $-2.93M 97.39%
2015 $-1.48M 19.24%
2014 $-1.24M 112.82%
2013 $-584.08K -86.59%
2012 $-4.35M -29.96%
2011 $-6.22M 1,573.65%
2010 $-371.45K 155.62%
2009 $-145.32K -97.37%
2008 $-5.53M -0.89%
2007 $-5.58M 173.13%
2006 $-2.04M -20.13%
2005 $-2.56M 42.56%
2004 $-1.80M 29.13%
2003 $-1.39M -33.40%
2002 $-2.09M 96.03%
2001 $-1.06M 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -83,669.91%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -31,004.03%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -25,675.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B 48,807.15%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH